Illexcor Therapeutics, Inc.

CIK 2132799 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Illexcor Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 8, 2026D0002132799-26-000001